{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T11:41:05Z","timestamp":1788090065824,"version":"build-2803163510"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,20]]},"DOI":"10.7759\/cureus.109262","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:21:21Z","timestamp":1779276081000},"source":"Crossref","is-referenced-by-count":1,"title":["Dupilumab-Associated Severe Headaches in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP): A Report of Two Cases With Resolution After Cessation"],"prefix":"10.7759","author":[{"given":"Michael","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaip.2016.04.012","article-title":"Chronic rhinosinusitis with nasal polyps","volume":"4","author":"Stevens WW","year":"2016","unstructured":"Stevens WW, Schleimer RP, Kern RC. Chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol Pract. 2016, 4:565-72. 10.1016\/j.jaip.2016.04.012","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref2","article-title":"Dupilumab (Dupixent): an interleukin-4 receptor antagonist for atopic dermatitis","volume":"43","author":"D'Ippolito D","year":"2018","unstructured":"D'Ippolito D, Pisano M. Dupilumab (Dupixent): an interleukin-4 receptor antagonist for atopic dermatitis. P T. 2018, 43:532-5.","journal-title":"P T"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31881-1","article-title":"Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials","volume":"394","author":"Bachert C","year":"2019","unstructured":"Bachert C, Han JK, Desrosiers M, et al.. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019, 394:1638-50. 10.1016\/S0140-6736(19)31881-1","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211887","article-title":"Interleukin-4 receptor signaling modulates neuronal network activity","volume":"219","author":"Hanuscheck N","year":"2022","unstructured":"Hanuscheck N, Thalman C, Domingues M, et al.. Interleukin-4 receptor signaling modulates neuronal network activity. J Exp Med. 2022, 219:e20211887. 10.1084\/jem.20211887","journal-title":"J Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.1685-15.2015","article-title":"Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage","volume":"35","author":"Zhao X","year":"2015","unstructured":"Zhao X, Wang H, Sun G, Zhang J, Edwards NJ, Aronowski J. Neuronal interleukin-4 as a modulator of microglial pathways and ischemic brain damage. J Neurosci. 2015, 35:11281-91. 10.1523\/JNEUROSCI.1685-15.2015","journal-title":"J Neurosci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00280.2022","article-title":"Sensitization of colonic nociceptors by IL-13 is dependent on JAK and p38 MAPK activity","volume":"324","author":"Barker KH","year":"2023","unstructured":"Barker KH, Higham JP, Pattison LA, Chessell IP, Welsh F, Smith ES, Bulmer DC. Sensitization of colonic nociceptors by IL-13 is dependent on JAK and p38 MAPK activity. Am J Physiol Gastrointest Liver Physiol. 2023, 324:G250-61. 10.1152\/ajpgi.00280.2022","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-019-0216-y","article-title":"Does inflammation have a role in migraine?","volume":"15","author":"Edvinsson L","year":"2019","unstructured":"Edvinsson L, Haanes KA, Warfvinge K. Does inflammation have a role in migraine?. Nat Rev Neurol. 2019, 15:483-90. 10.1038\/s41582-019-0216-y","journal-title":"Nat Rev Neurol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/414993-dupilumab-associated-severe-headaches-in-chronic-rhinosinusitis-with-nasal-polyposis-crswnp-a-report-of-two-cases-with-resolution-after-cessation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T11:21:22Z","timestamp":1779276082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/414993-dupilumab-associated-severe-headaches-in-chronic-rhinosinusitis-with-nasal-polyposis-crswnp-a-report-of-two-cases-with-resolution-after-cessation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":7,"URL":"https:\/\/doi.org\/10.7759\/cureus.109262","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,20]]}}}